PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 32; no. 15_suppl; p. 4022
Main Authors Gill, Sharlene, Ko, Yoo-Joung, Cripps, M. Christine, Beaudoin, Annie, Dhesy-Thind, Sukhbinder K., Zulfiqar, Muhammad, Zalewski, Pawel, Do, Thuan, Cano, Pablo Oscar, Lam, Wendy, Dowden, Scot D., Grassin, Helene, Stewart, John, Moore, Malcolm J.
Format Journal Article
LanguageEnglish
Published 20.05.2014
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2014.32.15_suppl.4022